In addition, treatment with human MOTS‐c peptide by intraperitoneal injection in mice has been demonstrated to exert its metabolic‐regulatory effects, such as improved insulin sensitivity, reduced body weight, and prevented high fat diet‐induced obesity and insulin resistance in mice.15 Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.